Rafferty Asset Management’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.09M Buy
101,786
+15,950
+19% +$687K 0.02% 456
2025
Q4
$4.35M Sell
85,836
-1,661
-2% -$59K 0.02% 468
2025
Q3
$2.54M Buy
87,497
+15,429
+21% +$357K 0.01% 588
2025
Q2
$1.7M Sell
72,068
-12,808
-15% -$288K 0.01% 645
2025
Q1
$2.04M Sell
84,876
-2,810
-3% -$90.3K 0.01% 576
2024
Q4
$3.71M Buy
87,686
+8,741
+11% +$387K 0.01% 472
2024
Q3
$3.49M Sell
78,945
-42,811
-35% -$1.62M 0.01% 492
2024
Q2
$4.41M Sell
121,756
-53,027
-30% -$2.1M 0.02% 448
2024
Q1
$7.54M Buy
174,783
+4,025
+2% +$143K 0.03% 362
2023
Q4
$2.63M Buy
170,758
+34,381
+25% +$437K 0.01% 602
2023
Q3
$1.87M Buy
+136,377
New +$2.34M 0.01% 627

Other funds holding VERA